Lapatinib ditosylate
98%
- Product Code: 52266
CAS:
388082-77-7
| Molecular Weight: | 925.46 g./mol | Molecular Formula: | C₄₃H₄₂ClFN₄O₁₀S₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09264195 | |
| Melting Point: | 240-242°C | Boiling Point: | 750.7°C |
| Density: | Storage Condition: | room temperature, dry |
Product Description:
Lapatinib ditosylate is primarily used in the treatment of certain types of breast cancer, particularly those that are HER2-positive. It works by inhibiting the tyrosine kinase activity of the HER2/neu and EGFR receptors, which are often overexpressed in these cancers, thereby slowing down or stopping the growth of cancer cells. This medication is typically administered in combination with other chemotherapy agents, such as capecitabine, to enhance its efficacy. It is especially beneficial for patients who have not responded adequately to other treatments like trastuzumab. Lapatinib ditosylate is also being investigated for its potential use in other cancers where HER2 signaling plays a crucial role, offering hope for expanded therapeutic applications in the future.
Product Specification:
| Test | Specification |
|---|---|
| Purity | 98-100 |
| MELTING POINT | 237-245 |
| APPEARANCE | SOLID |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿2,540.00 |
+
-
|
| 1.000 | 10-20 days | ฿5,810.00 |
+
-
|
| 5.000 | 10-20 days | ฿25,840.00 |
+
-
|
Lapatinib ditosylate
Lapatinib ditosylate is primarily used in the treatment of certain types of breast cancer, particularly those that are HER2-positive. It works by inhibiting the tyrosine kinase activity of the HER2/neu and EGFR receptors, which are often overexpressed in these cancers, thereby slowing down or stopping the growth of cancer cells. This medication is typically administered in combination with other chemotherapy agents, such as capecitabine, to enhance its efficacy. It is especially beneficial for patients who have not responded adequately to other treatments like trastuzumab. Lapatinib ditosylate is also being investigated for its potential use in other cancers where HER2 signaling plays a crucial role, offering hope for expanded therapeutic applications in the future.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :